BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11895618)

  • 21. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
    Aspinall AI; Pinto A; Auer IA; Bridges P; Luider J; Dimnik L; Patel KD; Jorgenson K; Woodman RC
    Blood Cells Mol Dis; 1999; 25(3-4):227-38. PubMed ID: 10575548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
    Bleesing JJ; Brown MR; Straus SE; Dale JK; Siegel RM; Johnson M; Lenardo MJ; Puck JM; Fleisher TA
    Blood; 2001 Oct; 98(8):2466-73. PubMed ID: 11588044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The autoimmune lymphoproliferative syndrome: an experiment of nature involving lymphocyte apoptosis.
    Fleisher TA
    Immunol Res; 2008; 40(1):87-92. PubMed ID: 18193364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
    Fisher GH; Rosenberg FJ; Straus SE; Dale JK; Middleton LA; Lin AY; Strober W; Lenardo MJ; Puck JM
    Cell; 1995 Jun; 81(6):935-46. PubMed ID: 7540117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
    Straus SE; Jaffe ES; Puck JM; Dale JK; Elkon KB; Rösen-Wolff A; Peters AM; Sneller MC; Hallahan CW; Wang J; Fischer RE; Jackson CE; Lin AY; Bäumler C; Siegert E; Marx A; Vaishnaw AK; Grodzicky T; Fleisher TA; Lenardo MJ
    Blood; 2001 Jul; 98(1):194-200. PubMed ID: 11418480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression.
    Lopatin U; Yao X; Williams RK; Bleesing JJ; Dale JK; Wong D; Teruya-Feldstein J; Fritz S; Morrow MR; Fuss I; Sneller MC; Raffeld M; Fleisher TA; Puck JM; Strober W; Jaffe ES; Straus SE
    Blood; 2001 May; 97(10):3161-70. PubMed ID: 11342444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics of systemic autoimmunity in mouse models of lupus.
    Kono DH; Theofilopoulos AN
    Int Rev Immunol; 2000; 19(4-5):367-87. PubMed ID: 11016424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.
    Siegel RM; Frederiksen JK; Zacharias DA; Chan FK; Johnson M; Lynch D; Tsien RY; Lenardo MJ
    Science; 2000 Jun; 288(5475):2354-7. PubMed ID: 10875918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?
    van der Burg M; de Groot R; Comans-Bitter WM; den Hollander JC; Hooijkaas H; Neijens HJ; Berger RM; Oranje AP; Langerak AW; van Dongen JJ
    Pediatr Res; 2000 Mar; 47(3):336-43. PubMed ID: 10709732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.
    Rieux-Laucat F; Blachère S; Danielan S; De Villartay JP; Oleastro M; Solary E; Bader-Meunier B; Arkwright P; Pondaré C; Bernaudin F; Chapel H; Nielsen S; Berrah M; Fischer A; Le Deist F
    Blood; 1999 Oct; 94(8):2575-82. PubMed ID: 10515860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
    Wang J; Zheng L; Lobito A; Chan FK; Dale J; Sneller M; Yao X; Puck JM; Straus SE; Lenardo MJ
    Cell; 1999 Jul; 98(1):47-58. PubMed ID: 10412980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment.
    Lenardo M; Chan KM; Hornung F; McFarland H; Siegel R; Wang J; Zheng L
    Annu Rev Immunol; 1999; 17():221-53. PubMed ID: 10358758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkin's disease.
    Peters AM; Kohfink B; Martin H; Griesinger F; Wörmann B; Gahr M; Roesler J
    Exp Hematol; 1999 May; 27(5):868-74. PubMed ID: 10340403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of Fas and related death receptors in autoimmune and other disease states.
    Siegel RM; Fleisher TA
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):729-38. PubMed ID: 10329802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.
    Martin DA; Zheng L; Siegel RM; Huang B; Fisher GH; Wang J; Jackson CE; Puck JM; Dale J; Straus SE; Peter ME; Krammer PH; Fesik S; Lenardo MJ
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4552-7. PubMed ID: 10200300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
    Jackson CE; Fischer RE; Hsu AP; Anderson SM; Choi Y; Wang J; Dale JK; Fleisher TA; Middelton LA; Sneller MC; Lenardo MJ; Straus SE; Puck JM
    Am J Hum Genet; 1999 Apr; 64(4):1002-14. PubMed ID: 10090885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations.
    Vaishnaw AK; Orlinick JR; Chu JL; Krammer PH; Chao MV; Elkon KB
    J Clin Invest; 1999 Feb; 103(3):355-63. PubMed ID: 9927496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis.
    Infante AJ; Britton HA; DeNapoli T; Middelton LA; Lenardo MJ; Jackson CE; Wang J; Fleisher T; Straus SE; Puck JM
    J Pediatr; 1998 Nov; 133(5):629-33. PubMed ID: 9821419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathological findings in human autoimmune lymphoproliferative syndrome.
    Lim MS; Straus SE; Dale JK; Fleisher TA; Stetler-Stevenson M; Strober W; Sneller MC; Puck JM; Lenardo MJ; Elenitoba-Johnson KS; Lin AY; Raffeld M; Jaffe ES
    Am J Pathol; 1998 Nov; 153(5):1541-50. PubMed ID: 9811346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.